Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
LINKBAL, Returning to Profitability This Year
6046 LINKBAL INC. 【J-GAAP】
Earnings ReportLINKBAL INC. <6046> [TSE Growth] announced its financial results after the market closed on November 7th (15:30). The consolidated ordinary loss for the fiscal year ended September 2025 was loss of 83 million yen, a reduction in the deficit compared to loss of 83 million yen in the previous term. For the fiscal year ending September 2026, the consolidated ordinary profit/loss is expected to turn into a profit of 2 million yen.
In the most recent three-month period, from July to September (4Q), the consolidated ordinary profit/loss turned to a profit of 8 million yen (compared to a loss of 29 million yen in the same period last year). The operating profit/loss margin drastically improved from -12.1% in the same period last year to 2.1%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep, 2023 | 891 | -249 | -251 | -266 | -14.2 | 0 | Nov 8, 2023 | J-GAAP |
| Sep, 2024 | 968 | -123 | -123 | -124 | -6.7 | 0 | Nov 8, 2024 | J-GAAP |
| Sep, 2025 | 906 | -89 | -83 | -197 | -10.6 | 0 | Nov 7, 2025 | J-GAAP |
| YoY | -6.4% | +27.6% | +32.5% | -58.9% | -58.9% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep, 2025 Guidance | 904 | -83 | -83 | -204 | -10.9 | 0 | Aug 8, 2025 | J-GAAP |
| Sep, 2025 Results | 906 | -89 | -83 | -197 | -10.6 | 0 | Nov 7, 2025 | J-GAAP |
| Revision Rate | +0.2% | -7.2% | 0.0% | +3.4% | +2.8% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 442 | -62 | -62 | -64 | -3.5 | 0 | May 9, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | ー | ー | ー | ー | - | 0 | Nov 7, 2025 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep, 2024 | 968 | -123 | -123 | -124 | -6.7 | 0 | Nov 8, 2024 | J-GAAP |
| Sep, 2025 | 906 | -89 | -83 | -197 | -10.6 | 0 | Nov 7, 2025 | J-GAAP |
| Sep, 2026 Guidance | 971 | 2 | 2 | 1 | 0.1 | 0 | Nov 7, 2025 | J-GAAP |
| YoY | +7.2% | - | - | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 232 | -28 | -29 | -28 | -1.5 | -12.1 | Nov 8, 2024 | J-GAAP |
| Oct - Dec, 2024 | 229 | -26 | -26 | -28 | -1.5 | -11.4 | Feb 6, 2025 | J-GAAP |
| Jan - Mar, 2025 | 213 | -36 | -36 | -36 | -2.0 | -16.9 | May 9, 2025 | J-GAAP |
| Apr - Jun, 2025 | 225 | -32 | -29 | -144 | -7.7 | -14.2 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 239 | 5 | 8 | 11 | 0.6 | 2.1 | Nov 7, 2025 | J-GAAP |
| YoY | +3.0% | - | - | - | - |
Related Articles
Global Ltd, Jul-Sep (1Q) Ordinary Profit Decreases by 87%
Toyo Gosei, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 13%
COSMO BIO, Jan-Sep (Cumulative 3Q) Ordinary Profit Decreases by 4%, Jul-Sep Ordinary Profit Decreases by 45%
IPS, Jul-Sep (1Q) Ordinary Profit Increases by 2.3 times
Shimadzu, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 24%, Dividend Revised Upward by 1 Yen
Yossix, First Half Ordinary Profit Increases by 15%, Jul-Sep Ordinary Profit Increases by 30%
Monogatari, Jul-Sep (1Q) Ordinary Profit Increases by 22%
IPS, First Half Ordinary Profit Increases by 46%
SEIKO, First Half Ordinary Profit Increases by 17%, Jul-Sep Ordinary Profit Increases by 14%
Oncolys BioPharma, Jul-Sep (3Q) Net Income Loss Narrows